Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$3.91 USD
+0.07 (1.82%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.90 -0.01 (-0.26%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Myriad Genetics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MYGN 3.91 +0.07(1.82%)
Will MYGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MYGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MYGN
Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches
Should You Hold Myriad Genetics Stock in Your Portfolio Right Now?
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tempus AI Eyes Positive Adjusted EBITDA in 2025: Is It Taking Shape?
Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?
Down -49.47% in 4 Weeks, Here's Why Myriad (MYGN) Looks Ripe for a Turnaround
Other News for MYGN
Myriad Genetics (MYGN) Secures $200 Million Loan Facility from OrbiMed
Myriad genetics announces new $200 million credit facility
Myriad Genetics Announces New $200 Million Credit Facility | MYGN Stock News
Myriad Genetics announces $200M credit facility